LAFAYETTE HILL, Pa.--(BUSINESS WIRE)--IPS, a leading, full-service engineering, design, construction management, validation, and compliance company dedicated to assisting pharmaceutical and biotech companies, today announced a new agreement with Wuhan Pharmaceutical Industry Design Institute (WPIDI), a leading pharmaceutical engineering design institute in China to partner and jointly pursue pharmaceutical and biotechnology projects.
